Get started
Live feed
·
INSIDERFilingvia Quantisnow
Marker Therapeutics Inc. logo

SEC Form 4: Steve Elms bought $2,000,000 worth of Common Stock (1,142,857 units at $1.75)

ByQuantisnow·Wall Street's wire, on your screen.
MRKRMarker Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MRKR (Marker Therapeutics Inc.) and more on Quantisnow.